FindTrial
Sign In

Study on the influence of goal-directed fluid therapy based on FloTrac/Vigileo on the time of post-surgical hospitalization of patients undergoing liver resections

Study on the influence of goal-directed fluid therapy based on FloTrac/Vigileo on the time of post-surgical hospitalization of patients undergoing liver resections

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-15006832
Enrollment
Unknown
Registered
2015-05-25
Start date
2014-08-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver resection

Interventions

GDT group:Goal-directed fluid therapy based on SVV and CI measured by FloTrac/Vigileo
Control gruop:Fluid therapy according to the experience

Sponsors

Fuzhou General Hospital of Nanjing Military Command
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. age >=18 years; 2. ASA status I-III; 3. sinus rhythm; 4. undergoing elective open liver resection.

Exclusion criteria

Exclusion criteria: 1. age less than 18 years; 2. severe obesity (body mass index (BMI) >35); 3. permanent cardiac arrhythmias; 4. severe aortic regurgitation; 5. significant lung disease; 6. undergoing laparoscopic operation or emergency surgery; 7. expected surgery time less than 2 hours.

Design outcomes

Primary

MeasureTime frame
Length of I hospital stay after surgery;—

Countries

China

Contacts

Public ContactGuo-Zhong Chen
cgzssq2000@sina.com+86 591-24937084

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026